Roumell Asset Management, LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 92 filers reported holding ENZO BIOCHEM INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Roumell Asset Management, LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q2 2023$1,253,699
-43.0%
681,358
-24.7%
2.46%
-50.5%
Q1 2023$2,199,908
-27.7%
905,312
-57.5%
4.98%
-33.9%
Q4 2022$3,043,418
-42.9%
2,128,264
-11.0%
7.54%
-34.7%
Q3 2022$5,330,000
+7.7%
2,390,2110.0%11.54%
+19.8%
Q2 2022$4,948,000
-28.7%
2,390,211
-0.1%
9.63%
-14.1%
Q1 2022$6,939,000
-11.3%
2,392,642
-1.8%
11.21%
+7.5%
Q4 2021$7,822,000
-23.5%
2,436,771
-15.6%
10.43%
-23.0%
Q3 2021$10,219,000
+11.7%
2,886,7710.0%13.54%
+26.6%
Q2 2021$9,151,000
-2.8%
2,886,771
+5.5%
10.69%
-21.5%
Q1 2021$9,414,000
+34.9%
2,736,719
-1.2%
13.61%
+24.1%
Q4 2020$6,979,000
+40.5%
2,769,479
+17.6%
10.97%
+11.4%
Q3 2020$4,968,000
+262.6%
2,354,479
+284.9%
9.85%
+198.2%
Q2 2020$1,370,000
-67.1%
611,764
-50.5%
3.30%
-66.5%
Q2 2019$4,166,000
-19.7%
1,236,309
-34.9%
9.86%
-21.8%
Q1 2019$5,185,000
+68.8%
1,899,179
+71.8%
12.61%
+98.7%
Q4 2018$3,072,000
-2.6%
1,105,139
+44.4%
6.35%
+9.7%
Q3 2018$3,153,000765,2845.79%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2018
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders